Methods, systems, and apparatus for closed-loop neuromodulation
AssigneesSynchron Australia Pty Limited, The University of Melbourne
InventorsNicholas Lachlan Opie, Thomas James Oxley, Gil Simon Rind
Life of this patent
Estimating the term…
Abstract
Systems, apparatus, and methods for treating medication refractory epilepsy are disclosed. In one embodiment, a method of treating epilepsy is disclosed comprising detecting, using a first electrode array coupled to a first endovascular carrier, an electrophysiological signal of a subject. The method further comprises analyzing the electrophysiological signal using a neuromodulation unit electrically coupled to the first electrode array and stimulating an intracorporeal target of the subject using a second electrode array coupled to a second endovascular carrier implanted within a part of a bodily vessel superior to a base of the skull of the subject.
Claims18
A method of treating epilepsy, comprising:
- detecting, using a first electrode array, an electrophysiological signal of a subject, wherein the electrophysiological signal is a signal associated with or correlated with the onset of an epileptic seizure, wherein the first electrode array is coupled to a first endovascular carrier implanted within the subject, wherein the first endovascular carrier is a coiled microwire and wherein the first electrode array comprises electrodes arranged along a length of the coiled microwire;
- analyzing the electrophysiological signal using a neuromodulation unit implanted within the subject and electrically coupled to the first electrode array;
- and
- stimulating an intracorporeal target of the subject using a second electrode array in response to the electrophysiological signal detected, wherein the intracorporeal target is stimulated as part of a treatment for epilepsy, wherein the second electrode array is electrically coupled to the neuromodulation unit, wherein the second electrode array is coupled to a second endovascular carrier implanted within the subject, wherein the second endovascular carrier is implanted within the internal jugular vein superior to a jugular foramen of the subject.
Dependencies are inferred from the claim text.